The lower incidence of allergy and autoimmune diseases in developing countries has been associated with a high prevalence of parasitic infection. Here we provide direct experimental evidence that parasites can exert bystander immunosuppression of pathogenic T cells that mediate autoimmune diseases. Infection of mice with Fasciola hepatica resulted in recruitment or activation of regulatory dendritic cells and macrophages that expressed IL-10 and TGF-β.
Introduction
Epidemiological and experimental studies suggesting helminth infections can have a protective effect against the development of both autoimmune and allergic diseases (1), provoked a major shift in our understanding of T cell regulation.. The original hygiene hypothesis suggested that the increasing prevalence of allergies and asthma in industrialized countries may be linked to reduced infections with parasite and bacterial pathogens and was explained on the basis of Th1-Th2 cross regulation (2, 3) . However, this model did not account for the concomitant increase in incidences of many autoimmune diseases (4, 5) and the recently established role of IL-17-producing CD4 + T cells (Th17 cells) in autoimmune inflammation (6, 7) , nor the inverse correlation between exposure to Th2-inducing helminths and incidence of allergy (1, 8, 9) .
Since the initial description of Th1 and Th2 cells in the mid 1980's and the ensuing evidence of their reciprocal roles in controlling immune responses, a number of additional subtypes of CD4 + T cells have been defined. These include a number of distinct regulatory T (Treg) cell subsets, which play a major role in suppressing immune responses to self antigens, thereby maintaining tolerance and preventing autoimmunity (10) . Treg cells also function to control anti-pathogen effector T cell responses in order to limit immunopathology during infection (11) . More recently it has been demonstrated that Th17 cells, which develop via cytokine signals distinct from, and antagonised, by products of Th1 and Th2 lineages, are major mediators of inflammation and play a critical pathogenic role in many organ-specific autoimmune diseases (6, 7, 12) .
It has already been demonstrated that parasite-induced Treg cells can suppress Th2-medaited allergic responses (13) . Furthermore, it has been reported that colonization with
Heligmosomoides polygyrus suppress IL-17 production in the mesenteric lymph node (14) .
Experimental studies in mouse models have also demonstrated that helminth infections can ameliorate autoimmune diseases (15) (16) (17) , and although Th2 and anti-inflammatory cytokines have been implicated in protection, the role of Treg cells is still unclear. It has been demonstrated that Treg cells can protect against systemic inflammatory disease in mice (10, 18) , however, there is limited evidence that Foxp3 + natural Treg cells can suppress Th17 cells, especially in humans (19) . Furthermore, TGF-β has been shown to have both a positive and negative role in driving the development of Th17 cells (20) (21) (22) . In this study, we provide evidence that a helminth parasite, can suppress autoimmune disease through a TGF-β-dependent mechanism.
We previously reported that infection with the liver fluke Fasciola hepatica induces polarized Th2 responses in mice, suppressed Th1 responses and delayed clearance of the bacterial pathogen, Bordetella pertussis (23, 24 ). Here we demonstrate that this helminth parasite can modulate dendritic cell (DC) function to induce parasite-specific Treg cells that express IL-10
and TGF-β and inhibit the induction not only of Th1 and Th2 responses to the parasite. F.
hepatica infection also suppressed autoantigen-specific Th1 and Th17 responses that mediate experimental autoimmune encephalomyelitis (EAE).
Materials and Methods

Animals and F. hepatica infection
Female BALB/c and C57BL/6 mice were purchased from Harlan Olac (Bicester, UK 
Intracellular cytokine staining
To analyze cytokine production in DC and T cells from F. hepatica-infected mice, PEC were first incubated with 50% FCS in PBS for 20 mins and then stained with anti-CD11c and anti-CD4
respectively, without activation in vitro. In some experiments cells were cultured overnight in brefeldin A (BFA; 5μg/ml). Cells were washed, blocked with Fcγ blocker (Pharmingen 1 μg/ml), 
Statistical analysis
Data were compared by unpaired t-test or by one-or two-way ANOVA. Where significant differences were found, the Tukey-Kramer multiple comparisons test was used to identify differences between individual groups.
Results
F. hepatica infection modulates DC maturation and function
Following oral infection with F. hepatica metacercariae, juvenile parasites migrate from the gut through the peritoneal cavity to the liver. During this migratory period, cells of the peritoneal cavity are exposed to the flukes and their excretory-secretory products. Here we found that infection of mice with F. hepatica was associated with significant infiltration of DC and macrophages in the peritoneal cavity ( 
Infection with F. hepatica induces Treg cells with immunosuppressive function
Since F. hepatica infection induces TGF-β-and IL-10-producing macrophages and IL-10-producing DC and inhibits DC maturation, we examined the possibility that infection with F.
hepatica was also associated with the induction of antigen-specific Treg cells. F. hepaticaspecific CD4 + T cells lines were generated from the peritoneal cavity of infected mice and these were cloned by limiting dilution. Each of the T cell clones examined secreted IL-10 and low or undetectable concentrations of IL-5 or IFN-γ ( Fig. 2A) . ICS also demonstrated that a very high frequency (more than 70%) of T cells in the peritoneal cavity of F. hepatica-infected mice secrete IL-10 in the absence of IL-4 or IFN-γ production (Fig. 2B) . Phenotypic analysis revealed a high frequency of T cells from the peritoneal cavity of F. hepatica infected mice expressed CD25, CTLA-4, T1/ST2, IL-10R and CCR5 (Fig. 2C) , markers that are expressed on Treg cells.
However, there was only a modest increase in the frequency of CD4 + Foxp3 + in peritoneal cavity (CD4 + CD25 + Foxp3 + 8.6 ± 0.6 % versus 15.0 ± 1.3 % for control and infected mice respectively).
In contrast, the frequency of CD4 + T cells expressing LAP was significantly enhanced in infected compared with control mice (Fig. 2D) We next examined the ability of T cells from infected mice to suppress antigen-induced proliferation and cytokine production by effector T cells in vitro. CD4 + T cells purified from the peritoneal cavity of F. hepatica-infected mice significantly suppressed proliferation and IFN-γ production, by OVA-specific T cells from OVA TCR Tg mice (Fig. 4A) . Furthermore, a parasitespecific Treg clone generated from a F. hepatica infected mouse, which secreted IL-10 but not IFN-γ, significantly suppressed IFN-γ production by an OVA-specific Th1 clone (Fig 4B) .
Suppression of the Th1 clones was observed when co-cultured with the Treg clone and across a semi-permeable membrane (Fig. 4B ). These findings demonstrate that parasite-specific Treg cells from F. hepatica-infected mice exert bystander suppression of Th1 responses to an unrelated antigen via release of soluble factors.
Suppression of parasite-specific Th1 and Th2 responses during F. hepatica infection is mediated by IL-10
In (Fig. 5B ). These findings demonstrate that suppression of parasite-specific Th1 and Th2 responses in F. hepatica-infected mice is mediated by IL-10.
Infection with F. hepatica suppresses MOG-induced Th1 and Th17 cells and attenuates EAE through the induction of Treg cells
Self-antigen-specific Th1 and Th17 cells mediate pathology in a number of autoimmune diseases, including EAE (6, (25) (26) (27) (Fig. 6A) . In contrast, symptoms of EAE did not develop until day 14 in F. hepatica infected mice (Fig. 6) . Furthermore, the severity of disease in these mice was significantly reduced by F. hepatica infection.
The attenuation of clinical signs of disease by F. hepatica infection was associated with suppression of MOG-specific Th1 and Th17 cells (Fig. 6B) . In untreated mice, significant concentrations of IL-17 and IFN-γ, but no IL-10, were detected in supernatants of spleen cells stimulated ex vivo with MOG peptide. In contrast, T cells from F. hepatica-infected mice secreted significantly less MOG-specific IL-17 and IFN-γ and significantly higher concentrations of MOG-specific IL-10 ( Fig. 6B) .
F. hepatica mediated suppression of autoantigen-specific Th1 and Th17 responses and the attenuation of EAE is mediated by TGF-β, but not by IL-10
In order to examine the mechanism of suppression of autoantigen-specific T cell responses, we first examined the role of IL-10. EAE was induced in C57BL/6 WT and IL-10 -/-mice with and without infection with F. hepatica. Consistent with the immunosuppressive properties of IL-10, EAE was exacerbated in IL-10 -/-compared with WT mice (Fig. 7A ) and this was associated with elevated MOG-specific IL-17 production (Fig. 7B) . However, infection with F. hepatica significantly attenuated the clinical signs of EAE in IL-10 -/-as well as WT mice (Fig. 7A) . , as well as in WT mice, with a coincident elevation in MOG-specific IL-10 production in WT mice (Fig. 7B ). These data indicate that endogenous IL-10 does play a protective role in preventing the development of EAE, but demonstrate that that suppression of pathogenic autoantigen-specific T cells and the clinical signs of EAE by F. hepatica is not mediated by IL-
10.
We next examined the possible role of TGF-β in parasite-mediated suppression.
Administration of a neutralizing anti-TGF-β antibody in vivo to un-infected mice with EAE had little effect on the course of disease (Fig. 8A) . Infection with F. hepatica significantly attenuated the clinical symptoms of EAE in mice treated with a control antibody. The protective effect of the infection on development of EAE was reversed by the administration of anti-TGF-β in vivo; F.
hepatica infected mice treated with anti-TGF-β had more severe symptoms than non-infected mice or infected mice treated with a control antibody (Fig. 8A ).
The protective effect of F. hepatica infection was associated with a reduction in MOGspecific IL-17 and enhancement of endogenous and MOG-specific TGF-β production (Fig. 8B) .
Furthermore, surface expression of LAP, the amino-terminal domain of the TGF-β precursor peptide, was enhanced on CD4 + T cells from spleens of F. hepatica-infected with EAE, when compared with cells from non-infected mice with EAE (Fig. 8C) . The reversal by anti-TGF-β of the protective effect of F. hepatica and the increase severity of EAE correlated with enhancement of MOG-specific IL-17 production (Fig. 8B) . These findings suggest that in the absence of endogenous and parasite-induced TGF-β, F. hepatica infection may exacerbate EAE by enhancing the induction of pathogenic T cells, but that in the presence of a functional TGF-β response, F. hepatica suppresses EAE by inhibiting pathogenic T cells.
TGF-β suppresses IFN-γ production by T cells and IL-12, IL-23 and IL-1β production by DC
In order to investigate the possible mechanisms of TGF-β mediated suppression, we examined the influence of rTGF-β on Th1 and Th17 responses in vitro. We found that low concentrations of rTGF-β significantly suppressed in vitro production of IFN-γ by MOG-specific T cells from mice with EAE (Fig. 9A) . In contrast, these physiological concentrations of rTGF-β had no direct effect on MOG-specific IL-17 production.
Suppression of T cell responses can also be induced at the level of the APC, especially through the innate cytokines that promote the development and expansion of effector T cells.
Although IL-6 and TGF-β are considered to be the key cytokines that induce differentiation of (Fig. 9B ). Our findings suggest that F. hepatica attenuates EAE by inducing TGF-β production, which inhibits the production of innate cytokines that promote the induction and expansion of Th17 and Th1 cells and also has a direct inhibitory effect on IFN-γ production by Th1 cells.
DISCUSSION
There is now convincing evidence that exposure to certain infectious agents or their products may reduce the symptoms of allergy and asthma in humans (1, 8, 9) . This was initially explained on the basis of suppression of Th2-mediated allergic reactions by pathogen-induced Th1 responses.
There are also reports from studies with mouse models that infection with helminth parasites can suppress not only Th2-mediated allergic disorders, but also autoimmune diseases (15) (16) (17) . This is more difficult to explain on the basis of Th1-Th2 cross-regulation, since parasites have traditionally been associated with Th2 responses, whereas autoimmune diseases are thought to mediated by Th17 cells (6, 7, 12) , with a less clear cut but re-emerging evidence of a role for Th1 cells (25) (26) (27) . However, it has recently been reported that immunosuppression by a parasite infection is associated with the induction of natural Treg cells (13) . Here, we demonstrate that a * P < 0.05, ** P < 0.01, *** P < 0.001 versus LPS without TGF-β by ANOVA.
